Trial
NCT02212015
Evaluation of Votrient in Angiosarcoma
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Heidelberg University
Collaborators
Universitätsmedizin Mannheim; Helios Klinikum Berlin-Buch; University Hospital Dresden; Universitätsklinikum Hamburg-Eppendorf; University Hospital, Essen; Hannover Medical School; Klinikum der Universitaet Muenchen, Grosshadern; Medical University of Vienna; Medical University of Graz; Medical University Innsbruck; Novartis Pharmaceuticals
Condition
Angiosarcoma
Intervention
Pazopanib + Paclitaxel
Why stopped
Due to interim analysis' results and definitions fixed in protocol
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-22